Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

18 May 2017 07:00

RNS Number : 4771F
Wilmington PLC
18 May 2017
 

18 May 2017

 

Wilmington plc

Q3 Trading Update

 

Wilmington plc ("Wilmington" or "the business") the provider of information, education and networking services in Risk & Compliance, Professional, and Healthcare knowledge areas is today providing a trading update for the nine-month period to 31 March 2017.

 

Trading Update

Group revenue was up 13% (up 8% in constant currency) during the nine months ended 31 March 2017. Overall, revenue is in line with expectations, with good organic growth coming from our core growth areas of Risk & Compliance and the Healthcare businesses. Revenue growth was further supported by good contributions from the acquisitions made over the last two years and from the beneficial impact of currency translation. Offsetting this growth was, as previously reported, declines in some areas of the Professional division and the legacy charities and data suppression businesses.

During the nine-month period, Wilmington continued to see growth in reported operating profits, although this profit growth has been partially offset as reported in the interim results by continued investment across the business particularly in the US and in the compliance training areas where we see significant scope for stronger growth in the medium term.

 

Operational Review

Risk & Compliance 

Risk & Compliance again delivered strong revenue growth up 11% driven mainly by compliance training. In support of this growth and as reported in the interim results, we have continued to invest in new products, in the new North American operation and in additional support staff to expand our infrastructure and drive ICA membership. We have also been successful recently in winning two large international training programs which will benefit the business over the summer and we have brought in additional resources accordingly. This additional resource has further impacted margins in the short term but is expected to benefit contribution in 2017/18. Further investment continues to be made in our new North American compliance training business and in Compliance Week to expand its geographical reach in terms of events and information coverage.

Professional

Revenue was up 5% benefitting from favourable currency translation and the strong maiden performance from SWAT as well as our other accountancy training operations. However, the division continues to see the impact of the challenging conditions within the legal market as well as the impact of the weaker start to the financial year for AMT albeit we have recently regained stability in the Asia Pacific market.

The process for the planned disposal of Ark is underway and negotiations continue with potential buyers. Whilst Project Sixth Gear will provide benefits to the whole group, much of the work is centred around integrating the training businesses making up the bulk of the Professional division. This initiative is progressing well and we are attracting high calibre applicants for the divisional head role.

Healthcare 

Revenue was up 23% driven by organic growth across the board from our healthcare businesses and acquisitions made over the last two years. This was partially offset by continued declines in our legacy non-healthcare data suppression and charities businesses which make up around 20% of the division. HSJ, acquired on 31 January 2017 has also performed well and the HSJ team has been transferred to our Underwood Street premises. Integration is progressing on plan and is expected to be largely completed by the end of our 2016/17 financial year.

Cash Flow

Net debt as at 31 March 2017 was £51.4m (2016: £34.5m). This reflects strong cash generation and includes £20.3m paid in cash for two acquisitions made during the period. The Group has an overall borrowing facility of £85m which was extended from £65m in January 2017.

Adjusted measures

Effective from 30 June 2017 Wilmington will include share based payments costs within its definition of adjusted results. Share based payment costs amounted to £0.6m in 2015/16 and are not expected to be materially different during 2016/17.

Outlook

Wilmington continues to see the trends of tighter regulatory control and more complex legislation being implemented in most of our key markets, which in turn is driving demand for many of our products and services. We have and will continue to invest in our Compliance business to provide the infrastructure and support for anticipated future growth.

Despite the continued investment in infrastructure, the financial performance is in line with the Board's expectations and Wilmington is on track to deliver against expectations for the full year.

The information communicated in this announcement is inside information for the purposes of Article 7 of Market Abuse Regulation No. 596/2014

 

-End-

 

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Tony Foye, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Emma Appleton / Adam Davidson

 

020 7422 6800

 

 

 

020 3727 1000

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Capitalised at approximately £210 million, Wilmington floated on the London Stock Exchange in 1995.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUBVNRBWAVAAR
Date   Source Headline
21st Aug 20074:45 pmRNSTransaction in Own Shares
20th Aug 20072:55 pmRNSHolding(s) in Company
17th Aug 20076:09 pmRNSTransaction in Own Shares
16th Aug 20074:30 pmRNSTransaction in Own Shares
15th Aug 20077:01 amRNSDisposal of Non-Core Assets
13th Aug 20076:08 pmRNSHolding(s) in Company
13th Aug 20075:16 pmRNSTransaction in Own Shares
10th Aug 20077:00 amRNSNotice of Results
9th Aug 20074:41 pmRNSTransaction in Own Shares
7th Aug 20074:59 pmRNSTransaction in Own Shares
3rd Aug 20074:59 pmRNSTransaction in Own Shares
1st Aug 20075:13 pmRNSVoting Rights and Capital
31st Jul 20075:10 pmRNSTransaction in Own Shares
30th Jul 20075:18 pmRNSTransaction in Own Shares
26th Jul 20075:33 pmRNSTransaction in Own Shares
25th Jul 20075:26 pmRNSTransaction in Own Shares
20th Jul 20075:44 pmRNSShare buy-back programme
20th Jul 20077:00 amRNSPre-Close Trading Update
6th Jun 20077:00 amRNSProposed Disposal
22nd May 200710:43 amRNSHolding(s) in Company
22nd May 200710:35 amRNSHolding(s) in Company
14th May 20073:23 pmRNSDisposal of W.D.I.S. Limited
26th Mar 20077:01 amRNSChange of Adviser
1st Mar 20077:03 amRNSInterim Results
27th Feb 200710:32 amRNSHolding(s) in Company
30th Jan 200712:36 pmRNSNotice of Results
26th Jan 20075:44 pmRNSHolding(s) in Company
15th Dec 20062:54 pmRNSDirector/PDMR Shareholding
14th Dec 20067:00 amRNSTrading Statement
13th Dec 200611:02 amRNSDirector/PDMR Shareholding
12th Dec 20063:29 pmRNSTotal Voting Rights
7th Dec 200611:18 amRNSDirector/PDMR Shareholding
16th Nov 20062:23 pmRNSAnnual Information Update
15th Nov 20065:38 pmRNSAGM Statement
15th Nov 20065:04 pmRNSHolding(s) in Company
14th Nov 20063:13 pmRNSHolding(s) in Company
26th Oct 20064:05 pmRNSAnnual Report and Accounts
23rd Oct 200611:54 amRNSDirector/PDMR Shareholding
16th Oct 20067:01 amRNSAcquisition
21st Sep 20064:19 pmRNSDirector/PDMR Shareholding
18th Sep 20067:02 amRNSFinal Results
12th Sep 20065:31 pmRNSHolding(s) in Company
30th Aug 20062:51 pmRNSNotice of Results
21st Aug 20067:01 amRNSTermination of Discussions
21st Aug 20067:00 amRNSMerger Terminated
14th Aug 200610:41 amRNSRule 8.3- Wilmington Group
10th Aug 20061:28 pmRNSResult of EGM - Adjournment
9th Aug 20069:03 amRNSAdjournment of EGM
9th Aug 20067:00 amRNSAdjournment of EGM
7th Aug 20062:44 pmRNSRule 8.3- Wilmington Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.